Multiple Myeloma an Oncology Boosting Competitive Grant Program – Netherlands

Deadline: 30-Oct-24

Pfizer is pleased to announce the Multiple Myeloma an Oncology Boosting Competitive Grant Program.

Specific Area of Interest

• It is the intent to support quality improvement projects that focus on resolving gaps and/or barriers in delivering quality healthcare for people with Multiple Myeloma. Proposals will address one or more of the following:
  • Addressing disparities in the quality of care
    • Health inequities could be related to many different factors including geographic location, age, race/ethnicity, or socioeconomic status. Disparities in healthcare may be caused by patient factors such as health literacy, or healthcare professional or system-driven factors such as access to clinical trials or individual unconscious or conscious bias.
  • Psychological effect of Multiple Myeloma on patients and their caregivers
    • Psychological or social issues directly effecting the patient such as depression and social obstacles, but also the effect the disease and treatment have on family members and/or carers.
  • Improving the quality of treatment by exploring better ways to manage long term side effects
    • Examples of side effects may include fatigue, neuropathy, or infections
    • Proposals involving clinical research projects will not be considered for this RFP.
    • It is expected that projects will be evidence-based and the proposed evaluation will follow generally accepted scientific principles. During review the intended outcome of the project is given careful consideration and projects with the maximum likelihood to directly impact patient care will be given high priority.

Funding Information

• Individual projects requesting up to €50000 will be considered. The estimated total available budget related to this RFP is €150000.

Target Audience

• Oncologists and other healthcare professionals involved in the care of patients with Multiple Myeloma, patients and care givers and patient advocacy groups.

Eligibility Criteria

• Geographic Scope:
  • The Netherlands
• Applicant Eligibility Criteria
  • Only organizations are eligible to receive grants, not individuals or physician owned medical practice groups.
  • The following may apply: medical and nursing schools and academic centers, healthcare institutions (both large and small); professional associations; hospitals and community cancer centers, government agencies and nongovernment organizations (NGOs); Patient Advocacy Groups and other entities with a mission related to healthcare improvement.
  • Collaborations within institutions (e.g., between departments and/or interprofessional), as well as between different institutions / organizations / associations, are encouraged. Please note all partners must have a relevant role and the requesting organization must have a key role in the project.
  • Inclusion of multiple myeloma patients as members of the project team is encouraged.
  • The Project Lead must be an employee or independent contractor of the requesting organization.

For more information, visit Pfizer.